Navigation Links
Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
Date:9/18/2007

- Millennium on track to file sNDA in first quarter 2008 -

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that the interim analysis results of the large, international Phase III VISTA(1) trial in patients with newly diagnosed multiple myeloma showed that the therapy of VELCADE, melphalan and prednisone (VMP) demonstrated a highly statistically significant improvement in all efficacy measures, including time-to-disease progression, complete remission rate, progression-free survival and overall survival, compared to melphalan and prednisone (MP) alone. Based on the recommendation of an independent data monitoring committee (IDMC), which conducted the planned interim, the control arm of the trial was stopped early to allow patients still being treated with MP to have VELCADE added to their therapy.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"These results position VELCADE based therapy as a new standard of care for newly diagnosed multiple myeloma patients," said Paul Richardson, M.D., Associate Professor of Medicine, Harvard Medical School; Clinical Director, Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute Boston; and a lead investigator of the VISTA trial. "The combination of VELCADE with melphalan and prednisone surpassed all efficacy endpoints, including time-to-disease progression, complete remission rate, progression-free survival and overall survival, and did so, much earlier than expected. We are excited at the possibility this new therapy could be available to our patients sooner."

In the first
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
3. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
7. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015  Haemonetics Corporation (NYSE: ... Chief Operating Officer, will present at the JMP Securities ... on June 23 rd , 2015 at 11:30am ... Mr. Davies, presentation live via webcast at: http://wsw.com/webcast/jmp27/hae ... HAE ) is a global healthcare company dedicated ...
(Date:5/29/2015)... , May 29, 2015  World-renowned prostate surgeon and ... findings on the benefit of MR/Ultrasound Fusion-Guided Biopsy ... "Our Prostate Cancer Center at Lenox Hill Hospital ... Biopsy System in New York City . ... low risk prostate cancers. The use of an MRI makes ...
(Date:5/28/2015)... , May 28, 2015  Pharmaceutical ... new drugs and tests, and this is ... instruments that can assist them. This according to ... Information said instruments such as mass spectrometry, ... in the identification of drug targets and ...
Breaking Medicine Technology:MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3
... 2011 /PRNewswire/ -- MEDX, Inc., a ... the next generation T-Quest™ compact gamma camera.  The ... features expanded imaging capabilities to perform parathyroid, sentinel ... other small organ studies.  The Company also announced ...
... 6, 2011 Life Extension, a global authority on ... supplements, has launched a product featuring ChromaDex,s (CDXC.OB) pTeroPure ... food stores and natural retailers. Life Extension ... naturally found in blueberries.  Pterostilbene has been shown ...
Cached Medicine Technology:MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras 2MEDX Installs Two Next Generation T-Quest™ Compact Gamma Cameras 3Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 2Life Extension® Launches New Product Containing ChromaDex's pTeroPure® Pterostilbene 3
(Date:5/30/2015)... At 73 years old, Lynn Kendall is happily ... attributes to a lifetime of being health-conscious. She passes on ... of her new book titled “ Cook for Health and ... and Longevity” features a collection of recipes and ideas for ... It is designed to encourage a lifestyle of correct eating ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Cyclist ... tour, “Wheels for the World 2015: Piles of ... to raise awareness about hemophilia and encourage individuals ... Life. , Save One Life supports nearly ... eleven developing countries through direct sponsorships, scholarships and ...
(Date:5/30/2015)... San Luis Obispo insurance ... a free analysis and consultation for anyone interested in ... Awareness Month, which was created by the non-profit organization ... States such as Polk recognize the proclamation, and use ... possibility of disability, as well as the often-overlooked need ...
(Date:5/30/2015)... 30, 2015 The iconic American actor, ... be hosting a new segment on Medical Malpractice. This ... medical malpractice in the health care field. , According ... of medical malpractice suits were filed, roughly only 20% ... settled out of court, while the remaining 30% were ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 “ Milli the ... monthly AppWatch, which takes a look at the latest and ... Joe Toohey, the host of AppWatch and technology expert, conducted ... an aesthetic game that engages and educates children. , Interactive ... Unfortunately not all the content and games they are playing ...
Breaking Medicine News(10 mins):Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2
... preventing disease. In the future, skin ,cancer detection may be ... is a nine-year ,survivor of melanoma. He’s lucky doctors were ... found a primary, which is what you call the skin ... skin. It had already gotten into my lymph system,” he ...
... the first one to suspect health problems, including heart ... gum disease are at higher risk for heart attacks. ... heart disease, notes the Academy of General Dentistry. There's ... "I've helped patients with heart conditions by diagnosing dental ...
... another benefit of taking aspirin. A new study shows ... week may lower their risk of leukemia by more ... 28,000 women in the Iowa Women's Health Study to ... (NSAIDs), such as ibuprofen, could protect against leukemia. ,Results ...
... shows cholesterol-lowering effects from a pill formulated with ... first placebo-controlled clinical trial to confirm the cholesterol-lowering ... populations have suggested drinking tea has health benefits ... cholesterol. Studies confirming the causal relationship between tea ...
... benefit of vitamin D. ,Each year, 200,000 women in the ... shows one form of the vitamin may enhance the effect ... mice treated with radiation alone to mice exposed to both ... treatment, the tumor volume in those women treated //with EB ...
... their tedious marathons at the basin may do more harm ... people to brush too hard for too long, to the ... Hours of tests on brushing and scrubbing volunteers have found ... to gums,// particularly if the toothbrush user presses too hard. ...
Cached Medicine News:
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Our quick release buckle apron is user friendly and our large support straps criss-crossing the back allows proper placement of the belt at your waist. Built-in shoulder pads add to the comfort....
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Medicine Products: